The information contained on this page is intended
for US healthcare professionals only.  Patient siteFREE SAMPLES/COUPONS

The information contained on this page is intended
for US healthcare professionals only.  Patient siteFREE SAMPLES/COUPONS

The full clinical story of vazalore® IS ONE OF innovative technology

PAPERS

Pharmacokinetic and pharmacodynamic profile of a novel phospholipid aspirin formulation.
Angiolillo DJ, et al. Clin Pharmacokinet. 2022:1-15. Published online January 20, 2022. doi:10.1007/s40262-021-01090-2
Influence of lipid excipients on platelet function and the pharmacodynamic effects of aspirin.
Schneider DJ, et al. J Cardiovasc Pharmacol. 2021;78(2):297-301.

POSTERS/ABSTRACTS

Impact of sex on platelet inhibition by aspirin in obese patients with type 2 diabetes: a pooled, patient-level analysis of two randomised clinical trials.

Kimmelstiel C, et al. EuroIntervention. 2020;16(suppl AC):382.
Abstract accepted at: EuroPCR; May 19-22, 2020.

Hospital budget impact of switching to an alternative aspirin formulation with improved GI safety for treatment of acute cardiovascular events.

Chingcuanco F, et al. Value Health. 2019;22(suppl S2):S123.
Poster presented at: ISPOR; May 18-22, 2019; New Orleans, LA.

Limitations of enteric-coated aspirin underscore the need for a next generation, safer and effective aspirin option.

Chingcuanco F, et al. Value Health. 2019;22(suppl S2):S121.
Poster presented at: ISPOR; May 18-22, 2019; New Orleans, LA.

Improved pharmacologic profile of a novel, liquid aspirin formulation compared with enteric coated aspirin: a pooled, patient level analysis of two randomized crossover studies.

Bhatt DL, et al. J Am Coll Cardiol. 2020;75(11 suppl 1):29.
Poster presented at: American College of Cardiology’s 69th Annual Scientific Session & Expo; March 28-30, 2020; Chicago, IL.

Impact of weight on the antiplatelet effects of aspirin: results of a pooled analysis of two randomized crossover studies comparing a liquid aspirin formulation with enteric coated aspirin.

Bhatt DL, et al. J Am Coll Cardiol. 2020;75(11 suppl 1):1344.
Poster presented at: American College of Cardiology’s 69th Annual Scientific Session & Expo; March 28-30, 2020; Chicago, IL.

Bioavailability of aspirin in fasted and fed states of a novel pharmaceutical lipid aspirin complex formulation.

Angiolillo DJ, et al. Stroke. 2020;51:ATP432.
Poster presented at: International Stroke Congress (ISC); February 18-21, 2020; Los Angeles, CA.

Pharmacokinetic and pharmacodynamic assessment of a lipid-based aspirin formulation: results of a prospective, randomized, crossover study.

Angiolillo DJ, et al. Eur Heart J. 2019;40(suppl):1225.
Poster presented at: European Society of Cardiology Congress (ESC); August 31-September 4, 2019; Paris, France.

Have questions or want to learn more about PLx Pharma Inc. or VAZALORE? Call 1-888-842-3567 or
request to be contacted
by a VAZALORE Representative.

Learn how
VAZALORE works

 

Read VAZALORE 325 mg clinical results
 
 

Opportunity for innovation in
aspirin delivery